| Application no. and date | 14731782.0 (espacenet) (Federated) (European Patent Register), 20140506 | | Patent/reg. no. and date | DK/EP 2994126, 20180620 | | Publication date | 20160316 | | Priority no. and date | FR 1354211, 20130507 | | EP pub. no. and date |
EP 2994126 20160316 | | Effective date | | | Applicant/owner | Novartis AG, Lichtstrasse 35
4056 Basel, CH | | Applicant ref. no. | SH/GP/157487 | | Inventor | HIRAWAT, Samit, c/o Novartis Pharmaceuticals Corporation
One Health Plaza
East Hanover, New Jersey 07936-1080, US,
MASSACESI, Cristian, c/o Novartis Pharma S.A.S.
Boite Postale 308
F-92506 Rueil-Malmaison, FR,
DI TOMASO, Emmanuelle, c/o Novartis Institutes for BioMedical Research
Inc.
250 Massachusetts Avenue
Cambridge, Massachusetts 02139, US | | Representative | Budde Schou A/S, Dronningens Tværgade 30, 1302 København K | | Opponent | | | IPC Class | A61K 31/337 (2006.01) , A61K 31/506 (2006.01) , A61K 31/5395 (2006.01) , A61P 35/00 (2006.01) | | Title | Kombination af en PI3-kinaseinhibitor med paclitaxel til anvendelse ved behandlingen eller forebyggelsen af cancer i hoved og hals | | Int. application no. | IB2014061239 | | Int. publication no. | WO2014181252 | | Related patent (certificate) | | | Status | DK/EP patent | | Pædiatrisk forlængelse | - | | Udløbsdato for pædiatrisk forlængelse | - |
|
